POSTED: Thursday June 4th 2009
FOR IMMEDIATE RELEASE
Leading Merial® Equine Brands Become Official Products of United States Equestrian Federation
ZIMECTERIN® Gold (ivermectin/praziquantel) and EQUIOXX® (firocoxib) were recently added as official USEF deworming and pain management products, respectively.
Content provided by Merial®
Equine Pharmaceuticals and Bader Rutter & Associates
(Duluth,
GA)— The
National Governing Body for
Equestrian Sport and a world leader
in animal health are teaming up by adding two leading MERIAL® Brand
Products as official products of the United States Equestrian Federation
(USEF). ZIMECTERIN® Gold (ivermectin/praziquantel) and EQUIOXX®
(firocoxib) were recently added as official USEF deworming
and pain management products, respectively.
“MERIAL Brand Products have helped to keep horses healthy and competing at their highest level for many years now,” says Scott Carling, managing director of sales and sponsorships, USEF. “We are pleased to extend our partnership with Merial to better serve our members and their horses.”
ZIMECTERIN Gold is a broad-spectrum dewormer that helps control 47 species and stages of parasites.1 EQUIOXX is the first equine oral, nonsteroidal anti-inflammatory drug (NSAID) to be approved in more than 20 years and is currently approved for use up to 14 days in the USEF when used at the recommended dose.2
“Merial is committed to excellence in animal health,” says Steve Lerner, director of large-animal marketing, Merial. “That’s why we’re proud to partner with USEF. Like Merial, USEF is committed to outstanding equine health care and safety. As the official provider of pain management and dewormer products, we can work together to better provide quality equine health care for the equine athletes of USEF.”
ZIMECTERIN Gold and EQUIOXX join longstanding MERIAL
brands
GASTROGARD® (omeprazole) and ULCERGARD® (omeprazole) as
official equine pharmaceutical products. GASTROGARD is the first and only
FDA-approved product for the treatment of equine stomach ulcers, while
ULCERGARD is the first and only FDA-approved product for
the prevention of equine stomach ulcers.
“We understand the importance USEF members place on keeping their horses healthy and competing at the highest level,” Lerner says. “We know as the official manufacturer of these leading equine health care products, Merial can help to do just that.”
For more information, please contact Scott Carling, USEF Managing Director, Sales and Sponsorship, at scarling@usef.org or (859) 225-6928.
Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs approximately 5,400 people and operates in more than 150 countries worldwide. Its 2008 sales were nearly $2.6 billion. Merial Limited is a joint venture between Merck & Co., Inc. and sanofi-aventis. For more information, please see www.merial.com.
Warning: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all drugs out of reach of children. There have been rare reports of swelling and irritation of the mouth, lips, and tongue following administration of ZIMECTERIN Gold. These reactions have been transitory in nature. Do not use in other animal species as severe adverse reactions, including fatalities in dogs, may result.
As with any prescription medication, prior to use, your veterinarian should perform a physical examination and review your horse’s medical history. Your veterinarian will advise you to observe for signs of potential drug toxicity. As a class, nonsteroidal anti-inflammatory drugs may be associated with gastrointestinal and renal toxicity. Use with other NSAIDs, corticosteroids or nephrotoxic medication should be avoided. EQUIOXX has not been tested in horses less than 1 year.
GASTROGARD® (omeprazole) is indicated for the treatment and prevention of recurrence of gastric ulcers in horses and foals 4 weeks and older. In efficacy trials, no adverse reactions were observed. Safety in pregnant or lactating mares has not been determined. Do not use in horses intended for human consumption. Keep this and all drugs out of the reach of children.
ULCERGARD® (omeprazole) can be used in horses that weigh at least 600 pounds. The effectiveness of ULCERGARD in the prevention of gastric ulcers in foals and weanlings has not been evaluated. ULCERGARD may be used safely in breeding stallions. Safety in pregnant mares has not been determined.
®EQUIOXX and ZIMECTERIN are registered trademarks of Merial Limited. ®GASTROGARD and ULCERGARD are registered trademarks of the AstraZeneca Group of Companies. ã2009 Merial Limited. Duluth, GA. All rights reserved. EQUIZIM912 (2/09).
1ZIMECTERIN Gold product label.
2United States Equestrian Federation. Drugs and medications guidelines. 2007:2-3. Available at: http://www.usef.org/documents/competitions/2007/2007DrugsMedsGuidelines.pdf. Accessed January 26, 2009.
The vision of the United States Equestrian Federation® is to provide leadership
for equestrian sport in the United States of America by promoting the pursuit
of excellence from the grassroots to the Olympic Games, based on a
foundation of fair, safe competition and the welfare
of its human and equine athletes.
# # #
Keywords · USEF · Equestrian Sport
Name: Joanie Morris
Organization: US Equestrian
Email:
Phone: +1.(859) 258-2472
URL: http://www.usef.org/
Please refer all questions to the company listed above issuing the press release. SFC will not be able to assist you with any inquiries and disclaims any content in these press releases.
Print This Press Release
